These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10377280)

  • 21. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
    Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
    Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PML bodies: a meeting place for genomic loci?
    Ching RW; Dellaire G; Eskiw CH; Bazett-Jones DP
    J Cell Sci; 2005 Mar; 118(Pt 5):847-54. PubMed ID: 15731002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body language: the function of PML nuclear bodies in apoptosis regulation.
    Hofmann TG; Will H
    Cell Death Differ; 2003 Dec; 10(12):1290-9. PubMed ID: 12934066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role for PML and the nuclear body in genomic stability.
    Zhong S; Hu P; Ye TZ; Stan R; Ellis NA; Pandolfi PP
    Oncogene; 1999 Dec; 18(56):7941-7. PubMed ID: 10637504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The promyelocytic leukemia nuclear body: sites of activity?
    Eskiw CH; Bazett-Jones DP
    Biochem Cell Biol; 2002; 80(3):301-10. PubMed ID: 12123283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
    Adamson AL; Kenney S
    J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus.
    Müller S; Matunis MJ; Dejean A
    EMBO J; 1998 Jan; 17(1):61-70. PubMed ID: 9427741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
    Doucas V; Tini M; Egan DA; Evans RM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2627-32. PubMed ID: 10077561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.
    Janssen K; Hofmann TG; Jans DA; Hay RT; Schulze-Osthoff K; Fischer U
    Oncogene; 2007 Mar; 26(11):1557-66. PubMed ID: 16924230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The myxoid liposarcoma specific TLS-CHOP fusion protein localizes to nuclear structures distinct from PML nuclear bodies.
    Thelin-Järnum S; Göransson M; Burguete AS; Olofsson A; Aman P
    Int J Cancer; 2002 Feb; 97(4):446-50. PubMed ID: 11802205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
    Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
    Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The acute promyelocytic leukemia-specific PML/RAR alpha fusion protein reduces the frequency of commitment to apoptosis upon growth factor deprivation of GM-CSF-dependent myeloid cells.
    Rogaia D; Grignani F; Grignani F; Nicoletti I; Pelicci PG
    Leukemia; 1995 Sep; 9(9):1467-72. PubMed ID: 7658713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification.
    Seeler JS; Marchio A; Losson R; Desterro JM; Hay RT; Chambon P; Dejean A
    Mol Cell Biol; 2001 May; 21(10):3314-24. PubMed ID: 11313457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
    Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
    Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of PML in tumor suppression.
    Salomoni P; Pandolfi PP
    Cell; 2002 Jan; 108(2):165-70. PubMed ID: 11832207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular biology of acute promyelocytic leukemia.
    Slack JL; Gallagher RE
    Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.